-
Sanity Group: Transforming European Cannabis Policy, Public View Through Learning And Novelty
Monday, March 11, 2024 - 6:11pm | 704Sanity Group is leading a change in the perception and regulation of cannabis across Europe. Centering on the untapped potential of cannabinoids for health, the company based in Berlin is bridging historical misconceptions with modern recognition of cannabis’s benefits. Dual Approach:...
-
Moderna Hires Harvard Stem Cell Researcher Jonathan Hoggatt as Director of Hematology: What You Need to Know
Friday, March 5, 2021 - 12:01pm | 471Moderna, Inc. (NASDAQ: MRNA), which shot to prominence with its coronavirus vaccine program, is beefing up its research and development team. What Happened: Jonathan Hoggatt, who was a principal faculty member at Harvard Stem Cell Institute, has joined Cambridge, Massachusetts-based Moderna...
-
Importance Of Phase 1 Trials
Friday, July 22, 2016 - 2:18pm | 458Pharmaceutical companies are naturally in the business of selling a drug or therapy to patients suffering from an illness in disease. The process is often lengthy, expensive and could result in companies declaring bankruptcies — or reaping hundreds of millions of dollars in profit. For very...